Evidence map›Paper›PMID 33552600›Full record

ArticleNeurology research international2021

Sensitivity of Awaji Criteria and Revised El Escorial Criteria in the Diagnosis of Amyotrophic Lateral Sclerosis (ALS) at First Visit in a Tunisian Cohort.

Bademain Jean Fabrice Ido, Imen Kacem, Mahamadi Ouedraogo, Amina Nasri, Saloua Mrabet, Amina Gargouri, Mouna Ben Djebara, Bawindsongré Jean Kabore, Riadh Gouider

Abstract read
In one paragraph

Article in Neurology research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bademain Jean Fabrice IdoDepartment of Neurology, University Hospital Yalgado Ouedraogo, Ouagadougou, Burkina Faso.ORCID https://orcid.org/0000-0001-8975-6813
Imen KacemDepartment of Neurology, UR12SP21, Razi Hospital, Manouba, Tunisia.
Mahamadi OuedraogoDepartment of Neurology, University Hospital Yalgado Ouedraogo, Ouagadougou, Burkina Faso.
Amina NasriDepartment of Neurology, UR12SP21, Razi Hospital, Manouba, Tunisia.
Saloua MrabetDepartment of Neurology, UR12SP21, Razi Hospital, Manouba, Tunisia.
Amina GargouriDepartment of Neurology, UR12SP21, Razi Hospital, Manouba, Tunisia.
Mouna Ben DjebaraDepartment of Neurology, UR12SP21, Razi Hospital, Manouba, Tunisia.
Bawindsongré Jean KaboreDepartment of Neurology, University Hospital Yalgado Ouedraogo, Ouagadougou, Burkina Faso.
Riadh GouiderDepartment of Neurology, UR12SP21, Razi Hospital, Manouba, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmyotrophic lateral sclerosis (ALS) is a fatal disease whose diagnosis and early management can improve survival. The most used diagnostic criteria are the revised El Escorial criteria (rEEC) and Awaji criteria (AC). The comparison of their sensitivities showed contradictory results. Our study aimed to compare the sensitivities of these two criteria in the diagnosis of definite ALS, at first visit, in a Tunisian hospital cohort. MATERIALS AND

methodsThis was a retrospective study including 173 patients diagnosed with ALS at the Department of Neurology of the Razi Hospital between January 2003 and April 2018.After studying the clinical features of the disease in our study population,each patient was categorized according to the rEEC and AC based on data collected in his medical record during his first visit to our department. Then, we compared the sensitivities of these two criteria in the diagnosis of definite ALS.

resultsOur Tunisian cohort was characterized by a slower disease progression. The sensitivity of the AC (69.4%) was significantly higher than that of the rEEC (40.5%) (

conclusionOur study demonstrated that patients in AC are more sensitive than rEEC in the early diagnosis of ALS in our Tunisian cohort. However, this superiority is gradually reduced during the evolution of the disease.

Identifiers

PMID33552600
PMCPMC7847325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.